The Robot Report

  • Home
  • News
  • Technologies
    • Batteries / Power Supplies
    • Cameras / Imaging / Vision
    • Controllers
    • End Effectors
    • Microprocessors / SoCs
    • Motion Control
    • Sensors
    • Soft Robotics
    • Software / Simulation
  • Development
    • Artificial Intelligence
    • Human Robot Interaction / Haptics
    • Mobility / Navigation
    • Research
  • Robots
    • AGVs
    • AMRs
    • Consumer
    • Collaborative Robots
    • Drones
    • Exoskeletons
    • Industrial
    • Self-Driving Vehicles
    • Unmanned Maritime Systems
  • Markets
    • Agriculture
    • Healthcare
    • Logistics
    • Manufacturing
    • Mining
    • Security
  • Financial
    • Investments
    • Mergers & Acquisitions
    • Earnings
  • Resources
    • Careers
    • COVID-19
    • Digital Issues
    • Publications
      • Collaborative Robotics Trends
      • Robotics Business Review
    • RBR50 Winners 2022
    • Search Robotics Database
    • Videos
    • Webinars / Digital Events
  • Events
    • RoboBusiness
    • Robotics Summit & Expo
    • Healthcare Robotics Engineering Forum
    • DeviceTalks
    • R&D 100
    • Robotics Weeks
  • Podcast
    • Episodes
    • Leave a voicemail

J&J delaying Ottava surgical robot by 2 years

By Sean Whooley | October 19, 2021

Listen to this article
Voiced by Amazon Polly

Johnson & Johnson Ottava surgical robot

Johnson & Johnson (J&J) has had a “temporary setback” with its Ottava surgical robotic system. Speaking on the company’s third-quarter earnings call, EVP Joseph Wolk said that while the company maintains its commitment to developing a general surgery offering with Ottava, the platform’s development timeline has been pushed back about two years due to multiple factors.

The initial expectation was to begin the verification and validation processes for Ottava in 2021, followed by enrollment in clinical trials for the device in 2022.

“We recorded a partial in-process R&D charge for $900 million in the third quarter,” Wolk said. “The accounting for this charge contemplates a first-in-human delay of approximately two years from our earlier projections of the second half of 2022, reflecting technical development challenges and COVID-19-related disruptions, including supply chain constraints being experienced broadly across all industries. Clearly, we realize the importance that a differentiated digital robotic platform can have for patient outcomes and the market. We continue to invest in and be committed to the platform and we’ll provide updates to the external community as warranted.”

This news means Medtronic continues to pull ahead of J&J when it comes to taking on Intuitive Surgical, the space’s dominant player with its da Vinci robots. Medtronic’s Hugo platform received European approval last week.

J&J EVP Ashley McEvoy also touched on the Ottava setbacks during the call. She said that while transformational innovation “is all kinds of fun,” the complexities can lead to technical challenges.

“We are absolutely committed to resolving our challenges, continuing to invest and bringing to market a competitive, differentiated offering as soon as possible,” McEvoy said on Ottava.

During the company’s medical device update in November 2020, J&J unveiled the system and it touted as capable of offering unrivaled flexibility and control compared to the rest of the market. The term “Ottava,” in Italian, means to play music an octave higher, highlighting the company’s aim to proverbially go an octave higher in medical intervention, according to J&J’s robotics chief development officer Dr. Frederic Moll, an Intuitive Surgical co-founder who joined J&J through its acquisition of his Auris Health in 2019.

J&J designed Ottava with six arms to provide more control and flexibility in surgery, while its arms will be integrated into the operating table. Additionally, at the time of unveiling, the company said the platform has a zero-footprint design to enable patient access, increase space in the operating room and improve workflow.

Robot-assisted surgery remains a hot area in medtech — with Medtronic, J&J and a host of smaller companies seeking to compete against Intuitive.

Adam Sachs, CEO and founder of Vicarious Surgical, was recently a guest on The Robot Report Podcast. Vicarious is developing a robot-assisted surgical system that in 2019 won FDA breakthrough device designation for its virtual reality-based robot-assisted surgical device. He discussed the challenges and keys to developing the system, the opportunities ahead, and debuting on the NYSE via SPAC. You can listen to that interview below.

Editor’s Note: This article first appeared on sister website MassDevice.

Comments

  1. SadMummy says

    January 4, 2022 at 4:18 pm

    Sounds like another time capsule is on the way

    Reply

Tell Us What You Think! Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related Articles Read More >

ABB depalletizer replaces heavy lifting and improves efficiency
Researchers developing underwater map-making robot
Eureka Robotics brings in $4.5M in pre-Series A funding
NASCAR crash test
AB Dynamics’ robots at use crash testing NASCAR cars

2021 Robotics Handbook

The Robot Report Listing Database

Latest Robotics News

Robot Report Podcast

Agility Robotics gets a boost from Amazon; The US Alliance of Robotics Clusters is born
See More >

Sponsored Content

  • Meet Trey, the autonomous trailer (un)loading forklift
  • Kinova Robotics launches Link 6, the first Canadian industrial collaborative robot
  • Torque sensors help make human/robot collaborations safer for workers
  • Roller screws unlock peak performance in robotic applications
  • Making the ROS development cycle manageable

RBR50 Innovation Awards

Leave us a voicemail

The Robot Report
  • Mobile Robot Guide
  • Collaborative Robotics Trends
  • Field Robotics Forum
  • Healthcare Robotics Engineering Forum
  • RoboBusiness Event
  • Robotics Business Review
  • Robotics Summit & Expo
  • About The Robot Report
  • Subscribe
  • Advertising
  • Contact Us

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search The Robot Report

  • Home
  • News
  • Technologies
    • Batteries / Power Supplies
    • Cameras / Imaging / Vision
    • Controllers
    • End Effectors
    • Microprocessors / SoCs
    • Motion Control
    • Sensors
    • Soft Robotics
    • Software / Simulation
  • Development
    • Artificial Intelligence
    • Human Robot Interaction / Haptics
    • Mobility / Navigation
    • Research
  • Robots
    • AGVs
    • AMRs
    • Consumer
    • Collaborative Robots
    • Drones
    • Exoskeletons
    • Industrial
    • Self-Driving Vehicles
    • Unmanned Maritime Systems
  • Markets
    • Agriculture
    • Healthcare
    • Logistics
    • Manufacturing
    • Mining
    • Security
  • Financial
    • Investments
    • Mergers & Acquisitions
    • Earnings
  • Resources
    • Careers
    • COVID-19
    • Digital Issues
    • Publications
      • Collaborative Robotics Trends
      • Robotics Business Review
    • RBR50 Winners 2022
    • Search Robotics Database
    • Videos
    • Webinars / Digital Events
  • Events
    • RoboBusiness
    • Robotics Summit & Expo
    • Healthcare Robotics Engineering Forum
    • DeviceTalks
    • R&D 100
    • Robotics Weeks
  • Podcast
    • Episodes
    • Leave a voicemail